Literature DB >> 33434060

Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies.

Christoph Schmid1, Jürgen Kuball2, Gesine Bug3.   

Abstract

Entities:  

Year:  2021        PMID： 33434060     DOI： 10.1200/JCO.20.01719

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  αβ T-cell graft depletion for allogeneic HSCT in adults with hematological malignancies.

Authors:  Moniek A de Witte; Anke Janssen; Klaartje Nijssen; Froso Karaiskaki; Luuk Swanenberg; Anna van Rhenen; Rick Admiraal; Lotte van der Wagen; Monique C Minnema; Eefke Petersen; Reinier A P Raymakers; Kasper Westinga; Trudy Straetemans; Constantijn J M Halkes; Jaap-Jan Boelens; Jürgen Kuball
Journal:  Blood Adv       Date:  2021-01-12

2.  Donor lymphocyte infusions after haploidentical stem cell transplantation with PTCY: A study on behalf of the EBMT cellular therapy & immunobiology working party.

Authors:  Nicole Santoro; Jarl E Mooyaart; Raynier Devillier; Yener Koc; Jan Vydra; Luca Castagna; Zafer Gülbas; José Diez Martin; Mercedes Colorado Araujo; Alexander Kulagin; Mutlu Arat; Concepcion Herrera Arroyo; Maria Paola Martelli; Mauro Di Ianni; Jorinde D Hoogenboom; Liesbeth C de Wreede; Annalisa Ruggeri; Christian Chabannon
Journal:  Bone Marrow Transplant       Date:  2022-10-10       Impact factor: 5.174

3.  Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy.

Authors:  Pavan Bachireddy; Elham Azizi; Cassandra Burdziak; Vinhkhang N Nguyen; Christina S Ennis; Katie Maurer; Cameron Y Park; Zi-Ning Choo; Shuqiang Li; Satyen H Gohil; Neil G Ruthen; Zhongqi Ge; Derin B Keskin; Nicoletta Cieri; Kenneth J Livak; Haesook T Kim; Donna S Neuberg; Robert J Soiffer; Jerome Ritz; Edwin P Alyea; Dana Pe'er; Catherine J Wu
Journal:  Cell Rep       Date:  2021-11-09       Impact factor: 9.995

4.  Infectious disease in hematopoietic stem cell transplantation.

Authors:  Kamal Kant Sahu
Journal:  Ther Adv Infect Dis       Date:  2021-04-19

5.  Preemptive Interferon-α Therapy Could Protect Against Relapse and Improve Survival of Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: Long-Term Results of Two Registry Studies.

Authors:  Meng-Zhu Shen; Xiao-Hui Zhang; Lan-Ping Xu; Yu Wang; Chen-Hua Yan; Huan Chen; Yu-Hong Chen; Wei Han; Feng-Rong Wang; Jing-Zhi Wang; Xiao-Su Zhao; Ya-Zhen Qin; Ying-Jun Chang; Kai-Yan Liu; Xiao-Jun Huang; Xiao-Dong Mo
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

6.  Navigating preemptive and therapeutic donor lymphocyte infusions in advanced myeloid malignancies by high-sensitivity chimerism analysis.

Authors:  Michael Stadler; Letizia Venturini; Ivonne Bünting; Elke Dammann; Eva M Weissinger; Adrian Schwarzer; Christian Schultze-Florey; Steve Ehrlich; Dominik Markel; Catherina Lueck; Alexandra Gladysz; Tabea Fröhlich; Nouraldin Damrah; Gernot Beutel; Matthias Eder; Arnold Ganser; Lothar Hambach
Journal:  Front Oncol       Date:  2022-08-17       Impact factor: 5.738

Review 7.  Allogeneic Stem Cell Transplantation Platforms With Ex Vivo and In Vivo Immune Manipulations: Count and Adjust.

Authors:  Moniek de Witte; Laura G M Daenen; Lotte van der Wagen; Anna van Rhenen; Reiner Raymakers; Kasper Westinga; Jürgen Kuball
Journal:  Hemasphere       Date:  2021-06-01

Review 8.  The Role of γδ T Cells as a Line of Defense in Viral Infections after Allogeneic Stem Cell Transplantation: Opportunities and Challenges.

Authors:  Anke Janssen; Eline van Diest; Anna Vyborova; Lenneke Schrier; Anke Bruns; Zsolt Sebestyen; Trudy Straetemans; Moniek de Witte; Jürgen Kuball
Journal:  Viruses       Date:  2022-01-10       Impact factor: 5.048
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.